News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Inflazyme Pharmaceuticals Ltd. (IZP.TO): Orexo AB Shareholders Approve Acquisition of Biolipox AB



11/14/2007 9:22:00 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 13, 2007) - Inflazyme Pharmaceuticals Ltd. (TSX: IZP) today announced that the shareholders of Orexo AB (OMX Nordic List, Mid Cap:ORX) have approved the acquisition of Biolipox AB. The new entity has retained the name Orexo and the President and CEO of Biolipox, Dr. Torbjorn Bjerke, will be formally appointed as the President and CEO of the new entity once the transaction is closed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES